Evidence map›Paper›PMID 38184608›Full record

ArticleMolecular cancer2024

CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis.

Zaosong Zheng, Xiangbo Zeng, Yuanchao Zhu, Mengxin Leng, Zhiyong Zhang, Qiong Wang, Xiaocen Liu, Siying Zeng, Yongyuan Xiao, Chenxi Hu and 6 more

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. International journal of molecular sciences · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Unraveling the Predictive Value ofStem cells international · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Zaosong Zheng *Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Xiangbo Zeng *Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Yuanchao Zhu *Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Mengxin LengDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Zhiyong ZhangDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Qiong WangDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Xiaocen LiuDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Siying ZengSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Yongyuan XiaoDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Chenxi HuDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Shiyu PangDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Tong WangDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Bihong XuDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Peidan PengDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Fei LiDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. feili20700338@126.com.
Wanlong TanDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. twl@smu.edu.cn.
Nanfang Hospital · CNSouthern Medical University · CN

Funding

China Postdoctoral Science Foundation 2023M731561National Natural Science Foundation of China 82073162National Natural Science Foundation of China 82202877Natural Science Foundation of Guangdong Province 2021A1515010762Present Foundation of Nanfang Hospital, Southern Medical University 2021C002 and 2020Z005
6 · The paper itself

Abstract

backgroundRenal cell carcinoma (RCC) is one of the most common malignant tumor worldwide. Metastasis is a leading case of cancer-related deaths of RCC. Circular RNAs (circRNAs), a class of noncoding RNAs, have emerged as important regulators in cancer metastasis. However, the functional effects and regulatory mechanisms of circRNAs on RCC metastasis remain largely unknown.

methodsHigh-throughput RNA sequencing techniques were performed to analyze the expression profiles of circRNAs and mRNAs in highly and poorly invasive clear cell renal cell carcinoma (ccRCC) cell lines. Functional experiments were performed to unveil the regulatory role of circPPAP2B in the proliferation and metastatic capabilities of ccRCC cells. RNA pulldown, Mass spectrometry analysis, RNA methylation immunoprecipitation (MeRIP), RNA immunoprecipitation (RIP), co-immunoprecipitation (CoIP), next-generation RNA-sequencing and double luciferase experiments were employed to clarify the molecular mechanisms by which circPPAP2B promotes ccRCC metastasis.

resultsIn this study, we describe a newly identified circular RNA called circPPAP2B, which is overexpressed in highly invasive ccRCC cells, as determined through advanced high-throughput RNA sequencing techniques. Furthermore, we observed elevated circPPAP2B in ccRCC tissues, particularly in metastatic ccRCC tissues, and found it to be associated with poor prognosis. Functional experiments unveiled that circPPAP2B actively stimulates the proliferation and metastatic capabilities of ccRCC cells. Mechanistically, circPPAP2B interacts with HNRNPC in a m6A-dependent manner to facilitate HNRNPC nuclear translocation. Subcellular relocalization was dependent upon nondegradable ubiquitination of HNRNPC and stabilization of an HNRNPC/Vimentin/Importin α7 ternary complex. Moreover, we found that circPPAP2B modulates the interaction between HNRNPC and splicing factors, PTBP1 and HNPNPK, and regulates pre-mRNA alternative splicing. Finally, our studies demonstrate that circPPAP2B functions as a miRNA sponge to directly bind to miR-182-5p and increase CYP1B1 expression in ccRCC.

conclusionsCollectively, our study provides comprehensive evidence that circPPAP2B promotes proliferation and metastasis of ccRCC via HNRNPC-dependent alternative splicing and miR-182-5p/CYP1B1 axis and highlights circPPAP2B as a potential therapeutic target for ccRCC intervention.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsMicroRNAsAlternative SplicingCytochrome P-450 CYP1B1Heterogeneous-Nuclear Ribonucleoprotein Group CHeterogeneous-Nuclear RibonucleoproteinsHumansPolypyrimidine Tract-Binding ProteinRNA, CircularCYP1B1 protein, humanCytochrome P-450 CYP1B1Heterogeneous-Nuclear Ribonucleoprotein Group CHeterogeneous-Nuclear RibonucleoproteinsHNRNPC protein, humanMicroRNAsMirn182 microRNA, humanPolypyrimidine Tract-Binding ProteinPTBP1 protein, humanRNA, CircularAlternative splicingCircPPAP2BHNRNPCm6AmiRNA spongeNuclear translocation

Identifiers

PMID38184608
PMCPMC10770969
OpenAlexW4390638692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.